儿童中枢神经系统血管母细胞瘤:与成人型不同吗?25例回顾性系列研究
该研究回顾性分析2003年1月至2015年3月四川大学华西医院收治的25例16岁以下中枢神经系统血管母细胞瘤患儿,肿瘤位于小脑、脑干和脊髓者分别占40%、28%和32%,64%合并VHL综合征,全部实现全切除,术后76%症状改善,20%出现疾病进展,肿瘤相关囊肿(P=0.027)和VHL病(P=0.032)与术后结局显著相关。
要点
- 儿童血管母细胞瘤中64%合并VHL综合征,应高度怀疑VHL病。
- 肿瘤位于小脑、脑干和脊髓者分别占40%、28%和32%。
- 全部患儿实现全切除,76%症状改善,20%出现疾病进展。
核心结论
- 儿童血管母细胞瘤与成人病例相比具有许多不同的临床特征。
- 在儿童血管母细胞瘤中应高度怀疑VHL病。
- 尽管面临许多挑战,儿童血管母细胞瘤的手术结局良好。
- 必须终身随访以发现疾病进展。
研究设计与样本
- 回顾性研究,纳入2003年1月至2015年3月在四川大学华西医院治疗的所有中枢神经系统血管母细胞瘤患者,年龄小于16岁者纳入研究,共25例(女性15例、男性10例,平均年龄12.6±4.7岁,范围1-16岁)。
主要发现
- 肿瘤位于小脑、脑干和脊髓者分别占40%、28%和32%。
- 16例(64%)患有VHL综合征。
- 最常见的症状为与颅内压增高相关的症状,症状平均持续时间为1.5±2.1个月。
- 术前脑积水见于11例(44%)。
- 全部患儿实现全切除,临床症状改善19例(76%)、不变4例(16%)、加重2例(8%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pediatric hemangioblastomas are rare, and the clinical features, timing of surgical intervention, optimal treatment, and clinical outcomes are still unclear. METHODS: We performed a retrospective study of all patients with CNS hemangioblastomas who were treated at West China Hospital from January 2003 to March 2015. Patients under the age of 16 years were included in the study. The medical records of these patients were reviewed and statistically analyzed. RESULTS: Twenty-five children (15 females and ten males, [mean age 12.6 ± 4.7 years, range 1-16 years]) presented with hemangioblastomas. Tumors were detected in the cerebellum, brainstem, and spinal cord in 40, 28, and 32% of patients, respectively. Sixteen children (64%) had VHL syndrome. The most frequent symptoms were those related to increased intracranial pressure. The mean duration of symptoms was 1.5 ± 2.1 months. Preoperative hydrocephalus was noted in 11 children (44%). Gross total resection was achieved in all children. Clinical symptoms improved in 19 children (76%), unchanged in four children (16%), and aggravated in two children (8%), respectively. The mean follow-up was 44.5 ± 32.3 months. Five patients (20%) experienced disease progression. Using univariate analysis, both tumor-associated cysts (P = 0.027) and VHL disease (P = 0.032) were significantly related to postoperative outcomes. CONCLUSIONS: Pediatric hemangioblastomas have many different clinical features compared with adult cases. A high degree of suspicion for VHL disease should be raised in pediatric hemangioblastomas. Despite many challenges involved, surgical outcomes for pediatric hemangioblastomas are favorable. Lifelong follow-up is mandatory to detect the disease progression.
引用
- Cheng J, Liu W, Hui X, et al. Pediatric central nervous system hemangioblastomas: different from adult forms? A retrospective series of 25 cases. Acta Neurochir (Wien). 2017. PMID: 28752202. doi:10.1007/s00701-017-3275-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。